← Back to Search

Radiofrequency Ablation

Saline Enhanced Radiofrequency (SERF) ablation for Cardiovascular Disease (SERF VT EFS Trial)

N/A
Waitlist Available
Led By Douglas Packer, MD
Research Sponsored by Thermedical, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 30 days
Awards & highlights

SERF VT EFS Trial Summary

This study is evaluating whether a new device may help treat individuals with a common type of heart rhythm problem.

Eligible Conditions
  • Cardiovascular Disease
  • Heart Disease
  • Ventricular Tachycardia
  • Arrhythmia

SERF VT EFS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~by the end of the procedure
This trial's timeline: 3 weeks for screening, Varies for treatment, and by the end of the procedure for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
EFFICACY: Non-inducibility of the targeted clinical VT at end of ablation procedure.
SAFETY: SAEs that are probably or definitely device related within 30 days

SERF VT EFS Trial Design

1Treatment groups
Experimental Treatment
Group I: single armExperimental Treatment1 Intervention
Ablation of ventricular tachycardia with a saline-enhanced radiofrequency ablation catheter
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Saline Enhanced Radiofrequency (SERF) ablation
2018
N/A
~20

Find a Location

Who is running the clinical trial?

Thermedical, Inc.Lead Sponsor
2 Previous Clinical Trials
155 Total Patients Enrolled
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,836 Previous Clinical Trials
47,850,841 Total Patients Enrolled
Douglas Packer, MDPrincipal InvestigatorMayo Clinic
3 Previous Clinical Trials
859 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
SERF VT Ablation Early Feasibility Study (EFS)
2018. "SERF VT Ablation Early Feasibility Study (EFS)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03628534.
~2 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top